Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 November 2023 | Story NONSINDISO QWABE | Photo SUPPLIED
Thembinkosi Mkhwanazi
Egg-cellence: Thembinkosi Mkhwanazi won the central regional rounds of the Entrepreneurship Development in Higher Education (EDHE) competition for his egg business, Egg Palace.

What started as a side hustle to bring in extra income has turned into a thriving venture for UFS Qwaqwa Campus student Thembinkosi Mkhwanazi, who has begun reaping the rewards of his hard work.

In October, Mkhwanazi came out victorious at the central regional rounds of the Entrepreneurship Development in Higher Education (EDHE) competition in the Existing Businesses category for studentpreneurs for his egg business, Egg Palace. He is in his third year of a BA degree specialising in Psychology.

The EDHE entrepreneurship intervarsity competitions are intended to develop the entrepreneurial capacity of students with the intention of equipping them with the necessary skills needed to become economically active during and after their tertiary education. The 26 South African universities are grouped into six regions, and studentpreneurs get to pitch their innovative ideas or existing businesses for a chance to win the national rounds.

Mkhwanazi’s pitch came out on top, sealing his place at the nationals and a fighting chance at the R100 000 cash prize.

He started his egg-producing business in 2020 during the COVID-19 pandemic, buying organic eggs from a supplier and selling them to students and Qwaqwa community members.

Since then, his business has grown astoundingly, and Mkhwanazi now owns 165 chickens housed in a chicken house in Qwaqwa. This expansion has allowed Mkhwanazi to increase his egg production and cater to a wider customer base on the Qwaqwa Campus and within the local community.

“I won the internal rounds and the regional round, but I’ve realised that winning was a bonus. Since being on this journey, I’ve had the opportunity to meet a lot of people who’ve inspired me to grow my business and how to be unique. I also got to board a plane for the first time. The win has just been the cherry on top, but there’s so much that I’ve gained from this experience.”

Entrepreneurship helps students improve their (self-) employability and livelihoods 

He said he was inspired by the likes of UFS Qwaqwa Campus alum Jabulani Mabuza, who also won the 2022 EDHE regional rounds and made it to the nationals. Making it through the regionals was a wake-up call, he says, which motivated him to invest more time and effort into his business.

“I was in my comfort zone and wasn’t marketing my business properly, but I’ve since taken that seriously, and I’m already seeing a huge boost in sales and public awareness,” he said.

Mkhwanazi said he would like to see the university supporting student entrepreneurs to establish themselves. “There are a lot of us who are entrepreneurs who need more exposure and support to grow. The courses offered at our institution encourage us to be entrepreneurial. If we can be given more opportunities, we’d be able to grow and become self-reliant.”

The national leg of the EDHE competition will take place from 30 November to 1 December 2023.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept